TapewireFind a company

person · Reporting owner

JOYCE CHRISTOPHER J

Disclosed activity across 2 companies

Tapewire entity
54799
SEC CIK
0001032563

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AdaptHealth Corp.AHCO · Entity 5183General CounselMarch 09, 2023March 13, 2023
Alignment Healthcare, Inc.ALHC · Entity 4269Chief Legal and Admin. OfficerApril 01, 2026April 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AdaptHealth Corp.

Report date March 09, 2023 · Filed March 13, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect117,671 Reported balance After 2023-03-09 transaction · row 1
1 source row

Row 1 · 2023-03-09 · Grant · Acquired 27,578 · Balance 117,671

F1: These shares represent restricted stock units and will be settled in common stock upon vesting.

Common StockSEC Table I · non-derivativeIndirectSee footnote106,071 Reported balance Holding disclosure · report date 2023-03-09 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 106,071

F2: Securities held directly by Mayaid2001 LLC.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent restricted stock units and will be settled in common stock upon vesting.

F2: Securities held directly by Mayaid2001 LLC.

Alignment Healthcare, Inc.

Report date April 01, 2026 · Filed April 01, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect305,451 Reported balance After 2026-04-01 transaction · row 1
1 source row

Row 1 · 2026-04-01 · Sale · Disposed 18,013 · Balance 305,451

F1: Date of adoption of Rule 10b5-1 plan: 09/08/2025

F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Filing footnotes · ownership attribution and instrument terms

F1: Date of adoption of Rule 10b5-1 plan: 09/08/2025

F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2026 Filed Apr 1, 2026 18:16 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 18,013 $17.79 $320,492.70
Disclosure

SEC source: 0001628280-26-022893 · wk-form4_1775081790.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 305,451

F1 · kind: Date of adoption of Rule 10b5-1 plan: 09/08/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.57 to $17.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 18, 2026 Filed Mar 19, 2026 18:40 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 25,125 $17.84 $448,230.00
Disclosure

SEC source: 0001628280-26-019916 · wk-form4_1773960052.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,464

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 17:19 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 GrantCommon Stock 51,501 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-018892 · wk-form4_1773782389.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,589

F1 · shares: Represents 51,501 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 18:18 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 10,611 $20.03 $212,590.32
Disclosure

SEC source: 0001628280-26-000993 · wk-form4_1767741484.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 297,088

F1 · kind: Date of Rule 10b5-1 plan adoption: 09/08/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.46 to $20.35. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
December 29, 2025 Filed Dec 30, 2025 16:20 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 888 $19.38 $17,211.04
Disclosure

SEC source: 0001628280-25-059111 · wk-form4_1767129622.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 307,699

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.23 to $19.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
December 29, 2025 Filed Dec 30, 2025 16:20 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 15,299 $18.71 $286,176.97
Disclosure

SEC source: 0001628280-25-059111 · wk-form4_1767129622.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,587

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from 18.23 to $19.225. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
December 08, 2025 Filed Dec 8, 2025 18:26 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 19,706 $19.33 $380,905.16
Disclosure

SEC source: 0001628280-25-055906 · wk-form4_1765236399.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 323,886

F1 · kind: Date of Rule 10b5-1 plan adoption: 09/08/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.16 to $19.62. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
September 10, 2025 Filed Sep 10, 2025 20:11 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 8,811 $16.86 $148,513.81
Disclosure

SEC source: 0001032563-25-000006 · wk-form4_1757549468.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,592

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
September 10, 2025 Filed Sep 10, 2025 20:11 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 22,128 $16.23 $359,121.95
Disclosure

SEC source: 0001032563-25-000006 · wk-form4_1757549468.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,403

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
July 31, 2025 Filed Aug 1, 2025 18:28 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 15,491 $16.01 $247,950.50
Disclosure

SEC source: 0001628280-25-037274 · wk-form4_1754087278.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 374,531

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/27/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.00 to $16.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
May 01, 2025 Filed May 2, 2025 16:29 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 25,000 $16.87 $421,827.50
Disclosure

SEC source: 0001628280-25-021871 · wk-form4_1746217763.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 390,022

F1 · kind: Date of adoption of Rule 10b5-1 plan: 11/27/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.59 to $17.37. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
April 01, 2025 Filed Apr 2, 2025 19:05 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 25,000 $18.47 $461,632.50
Disclosure

SEC source: 0001628280-25-016334 · wk-form4_1743635108.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 415,022

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/27/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.14 to $18.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 19, 2025 Filed Mar 19, 2025 21:52 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 3,959 $16.96 $67,139.89
Disclosure

SEC source: 0001628280-25-013961 · wk-form4_1742435517.xml · nonDerivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,022

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 19, 2025 Filed Mar 19, 2025 21:52 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 7,057 $16.09 $113,533.02
Disclosure

SEC source: 0001628280-25-013961 · wk-form4_1742435517.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,981

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 18, 2025 Filed Mar 19, 2025 21:52 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 6,725 $16.89 $113,589.29
Disclosure

SEC source: 0001628280-25-013961 · wk-form4_1742435517.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 451,038

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 13, 2025 Filed Mar 17, 2025 18:04 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 GrantCommon Stock 70,789 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-013244 · wk-form4_1742249053.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457,763

F1 · shares: Represents (i) 56,452 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 14,337 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2024 fiscal year.

Read SEC document
March 06, 2025 Filed Mar 6, 2025 19:25 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 10,871 $15.53 $168,826.63
Disclosure

SEC source: 0001628280-25-011108 · wk-form4_1741307105.xml · nonDerivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 386,974

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This transaction does not represent a discretionary trade by the reporting person.

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.12 to $16.065. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 19:25 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 25,000 $15.58 $389,615.00
Disclosure

SEC source: 0001628280-25-011108 · wk-form4_1741307105.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 397,845

F2 · kind: Date of Rule 10b5-1 plan adoption: 11/27/2024

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.11 to $15.86. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 19:25 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 GrantCommon Stock 58,400 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-011108 · wk-form4_1741307105.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,845

F1 · shares: Represents shares of common stock that were acquired upon the certification by the Compensation Committee of the Alignment Healthcare, Inc. Board of Directors of the achievement of the performance objectives under performance share units ("PSUs") granted on September 14, 2023. The PSUs were scheduled to vest only if and to the extent that certain performance objectives (health plan revenue growth percentage, at-risk returning member medical benefit ratio and adjusted EBITDA, less capital expenditures) met or exceeded specified targets. In the aggregate, the performance objectives were achieved above target. Fifty percent (50%) of the granted PSUs were fully vested on the reported date of acquisition and fifty percent (50%) will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 18:19 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 667 $11.79 $7,865.73
Disclosure

SEC source: 0001628280-24-042225 · wk-form4_1727993952.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 364,445

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.77 to $11.845. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 18:22 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 10,159 $10.01 $101,711.91
Disclosure

SEC source: 0001628280-24-040386 · wk-form4_1726266164.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 365,112

F2 · kind: Date of adoption of Rule 10b5-1 plan: 3/15/2024

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
September 11, 2024 Filed Sep 13, 2024 18:22 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 24,467 $9.45 $231,213.15
Disclosure

SEC source: 0001628280-24-040386 · wk-form4_1726266164.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 375,271

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 17:29 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 4,541 $10.00 $45,421.81
Disclosure

SEC source: 0001628280-24-039740 · wk-form4_1725658168.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 399,738

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
September 04, 2024 Filed Sep 6, 2024 17:29 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 1,300 $10.00 $13,000.00
Disclosure

SEC source: 0001628280-24-039740 · wk-form4_1725658168.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 404,279

Read SEC document
August 02, 2024 Filed Aug 6, 2024 18:13 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 100 $9.01 $901.00
Disclosure

SEC source: 0001628280-24-035296 · wk-form4_1722982394.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 405,579

Read SEC document
August 02, 2024 Filed Aug 6, 2024 18:13 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 1,233 $9.00 $11,097.00
Disclosure

SEC source: 0001628280-24-035296 · wk-form4_1722982394.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 405,679

Read SEC document
July 15, 2024 Filed Jul 16, 2024 16:30 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 15,034 $9.05 $136,032.14
Disclosure

SEC source: 0001628280-24-031965 · wk-form4_1721161803.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 406,912

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $9.00 to $9.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
July 12, 2024 Filed Jul 16, 2024 16:30 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 300 $9.00 $2,700.00
Disclosure

SEC source: 0001628280-24-031965 · wk-form4_1721161803.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 421,946

Read SEC document
July 01, 2024 Filed Jul 3, 2024 17:37 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 666 $8.00 $5,328.00
Disclosure

SEC source: 0001628280-24-031190 · wk-form4_1720042618.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,246

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.00 to $8.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
June 14, 2024 Filed Jun 17, 2024 20:29 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 16,000 $8.01 $128,198.40
Disclosure

SEC source: 0001628280-24-028667 · wk-form4_1718670550.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,912

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.00 to $8.08. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 17:00 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 25,060 $5.05 $126,573.05
Disclosure

SEC source: 0001209191-24-005037 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,912

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:00 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 GrantCommon Stock 196,138 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004872 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 463,972

F1 · shares: Represents (i) 130,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 10,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 56,138 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year.

Read SEC document
September 13, 2023 Filed Sep 15, 2023 17:00 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 SaleCommon Stock 15,474 $5.20 $80,464.80
Disclosure

SEC source: 0001209191-23-049616 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,834

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

Read SEC document
September 06, 2023 Filed Sep 8, 2023 17:00 UTC Alignment Healthcare, Inc. ALHC · Entity 4269 GrantCommon Stock 283,308 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-048812 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,308

F1 · kind: Represents (i) 245,023 restricted stock units ("RSUs"), each RSU representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date, and (ii) 38,285 RSUs which vested immediately on the grant date, subject to forfeiture to the Company in the event of certain qualyfing terminations of employment, 100% if prior to the first anniversary of the grant date and 50% if after the first annivesary but prior to the second anniversary of the grant date.

Read SEC document
March 09, 2023 Filed Mar 13, 2023 18:18 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantCommon Stock 27,578 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-031863 · tm235381-13_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,671

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 17:26 UTC AdaptHealth Corp. AHCO · Entity 5183 Tax withholdingCommon Stock 639 $15.99 $10,217.61
Disclosure

SEC source: 0001104659-23-028026 · tm235381-10_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,093

F1 · shares: The reporting person surrendered 639 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant.

Read SEC document
February 01, 2023 Filed Feb 3, 2023 19:33 UTC AdaptHealth Corp. AHCO · Entity 5183 Tax withholdingCommon Stock 3,050 $21.38 $65,209.00
Disclosure

SEC source: 0001104659-23-010766 · tm235381-4_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,732

F1 · shares: The reporting person surrendered 3,050 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock unit grant.

Read SEC document
December 31, 2022 Filed Jan 4, 2023 18:28 UTC AdaptHealth Corp. AHCO · Entity 5183 Tax withholdingCommon Stock 8,491 $19.22 $163,197.02
Disclosure

SEC source: 0001104659-23-001020 · tm2232561-3_4seq1.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,782

F2 · shares: The reporting person surrendered 8,491 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant.

Read SEC document
December 31, 2022 Filed Jan 4, 2023 18:28 UTC AdaptHealth Corp. AHCO · Entity 5183 Disposition to issuerCommon Stock 2,546 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-001020 · tm2232561-3_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,273

F1 · shares: The reporting person surrendered 2,546 shares of restricted stock due to the company's final determination that certain stock price performance criteria of the company were not achieved.

Read SEC document
August 16, 2022 Filed Aug 23, 2022 17:55 UTC AdaptHealth Corp. AHCO · Entity 5183 SaleCommon Stock 100,000 $22.20 $2,219,530.00
Disclosure

SEC source: 0001104659-22-093765 · tm2224399-1_4seq1.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 106,071

F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on March 18, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

F3 · ownership.nature: Securities held directly by Mayaid2001 LLC.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 16:38 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantCommon Stock 6,120 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-025204 · tm225219-14_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,819

Read SEC document
February 01, 2022 Filed Feb 3, 2022 17:05 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantCommon Stock 28,880 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-011418 · tm225219-4_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,699

F1 · shares: These shares represent restricted stock units and will be settled in common stock upon vesting.

Read SEC document
January 01, 2022 Filed Jan 4, 2022 21:04 UTC AdaptHealth Corp. AHCO · Entity 5183 Tax withholdingCommon Stock 2,744 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-001092 · tm2136673-2_4seq1.xml · nonDerivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,819

F5 · price: The reporting person surrendered 2,744 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:04 UTC AdaptHealth Corp. AHCO · Entity 5183 Tax withholdingCommon Stock 9,367 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-001092 · tm2136673-2_4seq1.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,563

F4 · price: The reporting person surrendered 9,367 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:04 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantCommon Stock 6,873 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-001092 · tm2136673-2_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 206,071

F1 · kind: Shares issued as contingent consideration pursuant to the Agreement and Plan of Merger, dated as of July 8, 2019, as amended, by and among the issuer, BM AH Holdings, LLC, Access Point Medical, Inc., DFB Merger Sub LLC, AdaptHealth Holdings LLC, Clifton Bay Offshore Investments L.P., BlueMountain Foinaven Master Fund L.P., BMSB L.P., BlueMountain Fursan Fund L.P. and AH Representative LLC (the "Merger Agreement").

F2 · price: Pursuant to the Merger Agreement, the reporting person was entitled to receive the reporting person's pro rata portion of 1,000,000 shares of stock of the issuer based on certain conditions having been satisfied.

F3 · ownership.nature: Securities held directly by Mayaid2001 LLC.

Read SEC document
October 11, 2021 Filed Oct 13, 2021 21:15 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantCommon Stock 5,834 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-125947 · tm2129900-4_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,930

Read SEC document
January 28, 2021 Filed Feb 1, 2021 21:59 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantEmployee Stock Option (right to buy) · Derivative 166,667 $0.00 Strike: $11.50 $0.00
Disclosure

SEC source: 0001104659-21-010441 · tm214849-3_4seq1.xml · derivative · entry 3

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,667

Underlying: Class A Common Stock · 166,667 shares

Expires 2029-12-19

F2 · shares: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 166,667 shares.

F2 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 166,667 shares.

Read SEC document
January 28, 2021 Filed Feb 1, 2021 21:59 UTC AdaptHealth Corp. AHCO · Entity 5183 GrantClass A Common Stock 16,096 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-010441 · tm214849-3_4seq1.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,096

Read SEC document
January 28, 2021 Filed Feb 12, 2021 17:41 UTC Amendment AdaptHealth Corp. AHCO · Entity 5183 GrantEmployee Stock Option (right to buy) · Derivative 500,000 $0.00 Strike: $11.50 $0.00
Disclosure

SEC source: 0001104659-21-022173 · tm214849-13_4aseq1.xml · derivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Class A Common Stock · 500,000 shares

Expires 2029-12-19

F1 · shares: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 500,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

F1 · derivative.exercise_date: On December 19, 2019, the reporting person was granted an option to purchase 500,000 shares of Class A Common Stock of the issuer, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. The performance criteria for 2020 were met, resulting in the vesting of the option as to 500,000 shares in three equal annual installments on each of December 31, 2020, December 31, 2021 and December 31, 2022. This amendment is being filed to correct inadvertent typographical errors in the number of shares vested under the option held by the reporting person.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 21:30 UTC AdaptHealth Corp. AHCO · Entity 5183 Exercise / conversionClass B Common Stock · Derivative 266,331 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-20-133873 · tm2038090-1_4seq1.xml · derivative · entry 4

JOYCE CHRISTOPHER J · CIK 0001032563 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 266,331 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · price: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.exercise_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F5 · derivative.expiration_date: The Class B Common Stock is exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F3 · ownership.nature: Securities held directly by Mayaid2001 LLC.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.